YIL 781 hydrochloride

YIL 781 hydrochloride Suppliers list
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774 400-920-5774
Email: sales@glpbio.cn
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com

YIL 781 hydrochloride manufacturers

YIL 781 hydrochloride Basic information
Product Name:YIL 781 hydrochloride
Synonyms:YIL781 HCl;YIL781 hydrochloride,YIL-781 hydrochloride
CAS:1640226-17-0
MF:C24H28FN3O2.ClH
MW:445.96
EINECS:
Product Categories:
Mol File:1640226-17-0.mol
YIL 781 hydrochloride Structure
YIL 781 hydrochloride Chemical Properties
storage temp. Store at -20°C
solubility Soluble in DMSO
form A solid
color Off-white to light yellow
Safety Information
MSDS Information
YIL 781 hydrochloride Usage And Synthesis
UsesYIL781 hydrochloride is a potent and orally active ghrelin receptor (GHSR) antagonist. YIL781 hydrochloride produces a greater improvement in glucose homeostasis in rats. YIL781 hydrochloride inhibits the calcium response induced by ghrelin with pIC50 values of 7.90 and 8.27, respectively[1][2][3][4].
in vivo

YIL781 (0.1 to 5 μg/5 μl) attenuates ghrelin-induced up-regulation of the blood glucose level. The i.t. treatment with YIL781 alone does not affect the blood glucose level (F = 0.8160; P = 0.5095)[4].

Animal Model:Conscious mice[4].
Dosage:0.1 to 5 μg/5 μl.
Administration:Intrathecal (i.t.) injection.
Result:Attenuated ghrelin-induced up-regulation of the blood glucose level (F = 0.7506; P = 0.5729) (YIL781 5 g + ghrelin 5 g 9.1% at 30 min; 14.9% at 60 min).
The i.t. treatment with YIL781 alone did not affect the blood glucose level (F = 0.8160; P = 0.5095).
storageDesiccate at RT
References[1] William P Esler, et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss Endocrinology. 2007 Nov;148(11):5175-85. DOI:10.1210/en.2007-0239
[2] Timothy H. Moran, et al. Gut Peptides: Targets for Antiobesity Drug Development Endocrinology. 2009 Jun; 150(6): 2526–2530. DOI:10.1210/en.2009-0003
[3] Elisabetta Perdonà, et al. Pharmacological characterization of the ghrelin receptor antagonist, GSK1614343 in rat RC-4B/C cells natively expressing GHS type 1a receptors. Eur J Pharmacol. 2011 Jan 10;650(1):178-83. DOI:10.1016/j.ejphar.2010.10.042
[4] Yun-Beom Sim, et al. Ghrelin administered spinally increases the blood glucose level in mice. Peptides. 2014 Apr;54:162-5. DOI:10.1016/j.peptides.2014.01.015
YIL 781 hydrochloride Preparation Products And Raw materials
Tag:YIL 781 hydrochloride(1640226-17-0) Related Product Information
YIL 781 YIL 781 hydrochloride 2-methoxy-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-12-one 6-Methoxy-2,3-dimethylquinazolin-4(3H)-one NA Glucagon (swine), hydrochloride (1:)